Insider Transactions Reported by 18 Insiders of Protara Therapeutics, Inc.

Symbol
TARA on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Protara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jesse Shefferman CEO and President, Director $6,815,619 26 Jan 2026
Opaleye Management Inc. 10%+ Owner $3,399,232 11 Sep 2024
Jacqueline Zummo Chf Scientific Operations Off $790,788 -$96,145 -11% 26 Jan 2026
Patrick Fabbio Chief Financial Officer $427,647 26 Jan 2026
Leonardo Nicacio Chief Medical Officer $416,704 16 Jan 2026
William Conkling Chief Commercial Officer $405,080 16 Jan 2026
Hannah Fry VP, Controller $284,962 26 Jan 2026
Richard S. Levy Director $162,690 +$63,800 +65% 12 Jun 2025
Jathin Bandari Chief Medical Officer $108,305 19 Jan 2024
Blaine Davis Chief Financial Officer $39,464 15 Jul 2022
Martin Sebastian Olivo Chief Medical Officer $27,397 10 Jun 2021
LUKE M. BESHAR Director 12 Jun 2025
GREGORY SARGEN Director 12 Jun 2025
Cynthia Smith Director 12 Jun 2025
Michael Edward Solomon Director 12 Jun 2025
Barry P. Flannelly Director 12 Jun 2025
Jane Huang Director 12 Jun 2025
ROGER GARCEAU Director 12 Jun 2025

Recent Insider Transactions by Companies or Individuals for Protara Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.